U.S. Capital Markets Stock News

In recent weeks Ulta Beauty has expanded its emerging brand lineup with Nutrire’s exclusive US launch across Ulta.com and roughly 250 stores, while also confirming the conclusion of its Target shop‑in‑shop arrangement. Ulta Beauty additionally appointed PacSun CEO Brieane Olson to its board, replacing Kelly Garcia, who moved into the company’s chief technology officer role. These moves suggest Ulta Beauty is leaning harder into exclusive wellness and specialty brands while refreshing board...

Iovance Biotherapeutics stock has delivered a steep 217.1% return year to date, yet current checks point to shares trading on the expensive side when compared with fundamental metrics. For investors, that mix of strong momentum and a market multiple that screens as overvalued raises questions about how much upside is already reflected in the price. The year to date gain of 217.1% suggests expectations for Iovance Biotherapeutics have reset sharply higher and now carry a lot more...

Kroger stock has delivered a 36.9% total return over the past five years, yet with the shares down 19.9% over the last year and the valuation checks pointing to value in several areas, investors are weighing whether the current price still offers a reasonable entry point or is closer to fully reflecting the fundamentals. A 36.9% return over five years suggests Kroger has rewarded patient shareholders. This raises the question of how much of that progress is already reflected in today’s share...

IonQ (IONQ) stock has been in focus after a strong Q2 update, where management raised full year 2026 revenue guidance and highlighted rapid revenue growth alongside several new quantum collaboration agreements. See our latest analysis for IonQ. Following the Q2 earnings jump, IonQ’s share price has been choppy, with a 30 day share price return of 26.64% but a 90 day share price return that declined 26.37%, while the 3 year total shareholder return remains very large. If IonQ’s recent move has...

Sherwin-Williams has delivered a 33.2% gain over the past three years, yet the stock now trades on earnings multiples that lean expensive, while a Discounted Cash Flow (DCF) intrinsic value estimate points to a price that is close to fair value. With the broader valuation checks also coming in weak, investors are weighing recent returns against a thinner margin of safety. The 33.2% return over three years suggests Sherwin-Williams has rewarded patient shareholders, which can make fresh entry...

Robert Half stock has gained 59.3% year to date, yet its valuation checks send mixed signals, with an intrinsic value estimate based on a Discounted Cash Flow (DCF) model pointing to meaningful upside while market based multiples suggest the shares are on the expensive side. Year to date, Robert Half is up 59.3%. This puts more focus on whether the current price still leaves enough margin between the market value and the underlying cash flow potential. Expectations for the company’s ability...

The recent testing of Claude designed proteins, which bound to 14 of 15 targets in work involving Twist Bioscience (TWST), has drawn fresh attention to how AI could influence end to end drug development. See our latest analysis for Twist Bioscience. Twist Bioscience’s share price has reacted strongly to the Claude protein news and wider interest in AI driven drug discovery, with a 30 day share price return of 62.82% and a year to date share price return of 339.61%, while the 1 year total...

Why Maravai LifeSciences Holdings Stock Is Back in Focus After Q2 2026 Earnings Maravai LifeSciences Holdings (MRVI) moved back onto investor watchlists after reporting second quarter 2026 results, with higher sales, a smaller net loss and reiterated full year revenue guidance. See our latest analysis for Maravai LifeSciences Holdings. Maravai LifeSciences Holdings has seen strong momentum build around these results, with a 25.78% 1 day share price return and a 112.35% year to date share...

Recently, Deckers Outdoor has come under pressure as investors reacted to reports of weak constant-currency growth, pressured operating margins, and limited free cash flow that restricts investment and capital returns. Despite these operational headwinds, some analysts argue that Deckers’ shares still screen as undervalued on discounted cash flow models and market multiples, highlighting a tension between valuation support and business constraints. We’ll now examine how concerns about...

Recent commentary around Hut 8 (NasdaqGS:HUT) focuses on its push into large AI focused data center campuses and long term contracted capacity, while regulatory reviews in Texas raise questions about how quickly related cash flows might materialize. See our latest analysis for Hut 8. Hut 8’s latest US$82.08 share price comes after a 1-day share price return of 1.60%. However, the 7-day and 30-day share price returns are down 9.57% and 18.68% respectively. This recent weakness contrasts with a...

Old Dominion Freight Line stock has delivered a 47.0% gain over the past five years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to an overvalued picture rather than a clear bargain. A 47.0% return over five years suggests Old Dominion Freight Line has rewarded patient shareholders, which naturally raises the bar for what counts as good value today. Future cash flow growth and margin resilience can support the current share price. Any...

Amkor Technology stock has surged over the past year, yet its current US$50.89 share price still screens as cheap, with both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples pointing to undervaluation. Amkor Technology has returned 123.2% over the past year, which puts fresh focus on whether the current valuation still leaves room for further upside. The multi year packaging agreement with Nvidia can support expectations for future cash flows. However, the...

Oklo Inc. recently reported second-quarter 2026 results, with sales of US$1.21 million and a net loss of US$48.54 million, widening its per-share loss from continuing operations to US$0.28 compared with US$0.18 a year earlier. A day before releasing these results, Oklo achieved first criticality at its Groves low-power test reactor on private land under the U.S. Department of Energy’s Reactor Pilot Program, marking a key step toward building domestic isotope production capabilities for...

Fresh test track images of a camouflaged wagon believed to be an updated ET5 Touring have put NIO (NYSE:NIO) back in focus for investors watching the company’s product roadmap and demand trends. See our latest analysis for NIO. Those test track sightings come after a mixed stretch for NIO, with the stock’s 1-day share price return of 1.10% and 7-day gain of 0.88% sitting against a 90-day decline of 18.21% and a 5-year total shareholder return down 88.24%, pointing to pressure that has not yet...

In early August 2026, The Travelers Companies, Inc. expanded its Board from eight to nine directors and appointed former Dun & Bradstreet and Black Knight leader Anthony Jabbour as a director, assigning him to the Audit and Risk Committees. By adding a director with deep data, analytics, and fintech experience, Travelers is reinforcing its focus on information-driven risk assessment, financial oversight, and technology investment. We’ll now examine how Anthony Jabbour’s appointment to...

H&R Block (HRB) is back in focus after its latest quarterly and full year earnings update, which highlighted higher revenue and earnings per share, along with new guidance, an ongoing buyback and a higher dividend. See our latest analysis for H&R Block. The latest earnings release and guidance appear to have reset expectations around H&R Block, with a 30 day share price return of 25.3% and a 90 day share price return of 37.9%, while the 5 year total shareholder return of 141.49% points to a...

DraftKings Inc. recently launched syndication for a proposed US$600 million senior secured term loan B and secured commitments for a new US$750 million senior secured revolving credit facility maturing in 2031, intended to refinance part of its Convertible Notes due 2028 and bolster general corporate liquidity. Coming shortly after reporting a return to quarterly and year-to-date net losses versus the prior year, this larger and longer-dated revolving facility signals a clear emphasis on...

Record US national debt of about US$40t, rising interest costs and fresh spending linked to the war in Iran are reshaping where money flows in markets. Some stocks could feel squeezed by higher financing costs, while others may gain from shifting federal priorities. This article examines 3 U.S. Defense and Aerospace Stocks screener companies that appear especially exposed to these forces and explains what that might mean for your portfolio. The three U.S. defense and aerospace stocks covered...

Thermo Fisher Scientific (TMO) drew fresh attention after reporting quarterly revenue and earnings that exceeded analyst expectations, alongside completing a large Parkinson's proteomics project with The Michael J. Fox Foundation. See our latest analysis for Thermo Fisher Scientific. Thermo Fisher Scientific's recent earnings beat and the completion of the Parkinson's proteomics project have coincided with strong momentum, including a 16.6% 30 day share price return and a 24.5% 1 year total...

Advanced Drainage Systems, Inc. reported first-quarter 2026 results showing higher sales and earnings year over year, confirmed its fiscal 2027 net sales guidance range of US$3.35 billion to US$3.55 billion, and previously approved a quarterly cash dividend of US$0.20 per share, an 11% increase over the prior year amount, paid on September 15, 2026. The company also completed a sizeable share repurchase program totaling 10,564,000 shares for US$1,179.44 million, alongside increasing its...

Inspire Medical Systems was added in the past week to the Zacks Rank #1 (Strong Buy) list, after analysts lifted their current-year earnings consensus by very large over the last 60 days for its minimally invasive obstructive sleep apnea therapy business. This sharp upward revision in earnings forecasts highlights how quickly sentiment can shift for specialized medical technology firms when analysts reassess profit potential. Next, we’ll examine how Inspire’s inclusion in the Zacks Rank #1...

The Morning Bull - US Market Morning Update Thursday, Aug, 20 2026 US stock futures are pointing slightly higher this morning, with S&P 500 and Nasdaq futures both edging up as investors weigh softer inflation signals against signs of housing weakness. US 10 year Treasury yields are drifting lower ahead of Federal Reserve meeting minutes, which can hint at slightly cheaper borrowing costs over time for households and companies. At the same time, pending home sales fell 2.3% in July and...

In August 2026, Otis Worldwide Corporation was selected once again as the sole provider of advanced modernization and integrated vertical transportation solutions for the nearly 600-meter Tianjin 117 Tower, supplying 251 elevators and escalators, including SkyRise and digitally native Gen3 systems. This repeat win at a supertall landmark highlights Otis’s role in complex, large-scale modernization projects that span both commercial and high-traffic infrastructure environments. We’ll now...

GE Vernova (GEV) has come under pressure after a weaker U.S. industrial production report triggered a sector-wide pullback in industrial stocks, even as its AI driven nuclear fuel tracking work with SHINE draws attention. See our latest analysis for GE Vernova. Despite the macro driven pullback, GE Vernova still carries strong momentum, with a 45.31% year to date share price return and a 63.70% total shareholder return over the past year. If the recent focus on nuclear fuel and grid...